Zobrazeno 1 - 10
of 289
pro vyhledávání: '"Matthias Volkenandt"'
Autor:
Bühren, Ralf Van
Rezension zu: Angelika Nollert, Matthias Volkenandt, Rut-Maria Gollan, Eckhard Frick (Hg.): Kirchenbauten in der Gegenwart. Architektur zwischen Sakralität und sozialer Wirklichkeit; Regensburg: Verlag Friedrich Pustet 2011; 256 S., Hardcover, ca. 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0f53ca2a11899b69a4bedff2b047e66
Autor:
Dirk Schadendorf, Eckhard W. Breitbart, Christiane Weber, Axel Hauschild, Wolfgang Tilgen, Matthias Volkenandt, Carola Berking, Ralf Gutzmer, Claus Garbe, Roland Kaufmann, Peter Mohr
Publikováno v:
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 19:1682-1697
Autor:
Axel Hauschild, Christiane Weber, Peter Mohr, Matthias Volkenandt, Eckhard W. Breitbart, Carola Berking, Roland Kaufmann, Ralf Gutzmer, Claus Garbe, Dirk Schadendorf, Wolfgang Tilgen
Publikováno v:
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDGReferences. 19(11)
Autor:
Dieter Hölzel, Jutta Engel, Wilhelm Stolz, Anne Schlesinger-Raab, Rüdiger Hein, Gabriele Schubert-Fritschle, Matthias Volkenandt
Publikováno v:
International Journal of Dermatology. 52:693-704
Background Incidences of malignant melanoma continue to increase in fair-skinned populations. At least 80% of patients are diagnosed with localized disease and can expect a 5-year relative survival rate of >90%. Given that the median age at diagnosis
Autor:
Steffen Schubert, Inke R. König, Mladen V. Tzvetkov, Rotraut Mössner, Kristian Reich, Annika Schäfer, Steffen Emmert, Claudia Pföhler, Thomas Vogt, Michael P. Schön, Jörg Reichrath, Jochen Kruppa, Matthias Volkenandt, Carola Berking
Publikováno v:
Archives of Dermatological Research
Melanoma is one of the most aggressive human cancers. The vitamin D system contributes to the pathogenesis and prognosis of malignancies including cutaneous melanoma. An expression of the vitamin D receptor (VDR) and an anti-proliferative effect of v
Autor:
Wilhelm Stolz, Dieter Hölzel, Rüdiger Hein, Matthias Volkenandt, Jutta Engel, Anne Schlesinger-Raab, Gabriele Schubert-Fritschle
Publikováno v:
Annals of Oncology. 21:2428-2435
Background The incidence of melanoma is still increasing in fair-skinned populations. At least 80% of patients have localised disease and expect a 5-year relative survival of >90%. Patients and methods In 2003–2004, disease-free patients with local
Autor:
Monika-H. Schmid-Wendtner, Axel Hauschild, Folkhart Schmidt, Martin Horn, Astrid Friebe, Gesa Janssen, Charlie H. Goldsmith, Martin Schaefer, Matthias Volkenandt
Publikováno v:
Psychosomatics. 51:466-473
Background Adjuvant IFN- α treatment for patients with malignant melanoma is often complicated by depression. The influence of dosage, however, is unknown. Objective The authors sought to elucidate this dosage effect. Method Using the Zung Self-Rati
Autor:
Matthias Volkenandt, Susanne Rötzer, Jörg Boettjer, Axel Hauschild, Thomas Vogt, Ruthild Linse, Friederike Egberts, Thomas Eigentler, Sarah Heinze, Norbert H. Brockmeyer, Konstanze Spieth, Axel Hinzpeter, Martin Schaefer, Wolfgang Tilgen
Publikováno v:
Journal of Immunotherapy. 33:106-114
The purpose of the present study was to evaluate the incidence, spectrum and extent of psychiatric symptoms in patients with malignant melanoma (MM) before and during adjuvant treatment with interferon-alpha (IFN-alpha). 850 patients with cutaneous M
Autor:
Birger Konz, Thomas Ruzicka, Christian Kunte, Theda Schuh, Matthias Volkenandt, Monika-H. Schmid-Wendtner, Jens Baumert, Julia Eberle
Publikováno v:
Dermatologic Surgery. 35:1757-1765
BACKGROUND Sentinel lymph node biopsy (SLNB) reliably assesses the status of the regional lymph node basins and provides prognostic information in patients with cutaneous melanoma, but is logistically demanding and expensive. OBJECTIVE The aim of thi
Autor:
Rolf-Dieter Kortmann, Wilhelm Stolz, Günther Sebastian, Uwe Reinhold, Matthias Volkenandt, Bernhard Frerich, Ulrich Keilholz, Wolfgang Tilgen, Christoph Kettelhack, Axel Hauschild, Andreas Mackensen, Dirk Schadendorf, Reinhard Dummer, Gerold Schuler, Claus Garbe, Roland Kaufmann
Publikováno v:
Melanoma Research. 18:152-160
Systemic medical treatment of melanoma is administered in the adjuvant and palliative setting. Adjuvant therapy may be considered in patients with primary melanoma with more than 1.5 mm tumor thickness and with regional node metastasis. Presently no